The US Department of Agriculture announced several eight- and nine-figure funding initiatives to advance policy promises, including the Organic Transition Initiative.
The $300 million investment, described as a way to help farmers and producers of organic products build new and better markets and streams of income, aims to increase the number of organic farmers and make it easier for shoppers to get their hands on organic foods.
Since 2008, the number of non-certified organic farmers seeking to convert to organic status has decreased by nearly 71 percent.
According to Agriculture Secretary Tom Vilsack, farmers face challenging technical, cultural, and market shifts while transitioning to organic production, and even during the first years after successful organic certification.
The multi-phased, multi-agency initiative would expand USDA's support of organic farmers to help them with every step of their transition as they work to become certified and secure markets for their products.
The USDA also announced $550 million in funding to help "the next, diverse generation of agricultural professionals" — organic or not.
There is also a $121 million investment in critical infrastructure to fight climate change in vulnerable communities in rural America, and $65 million to improve water quality, roads, trails, and fish habitats nationwide.


Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady 



